483
SMS Pharmaceuticals LimitedFDA 483 - SMS Pharmaceuticals Limited - March 21, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of SMS Pharmaceuticals Limited, an API Non-Sterile Drug Substance Manufacturer in Bachupally, India, identified a significant deficiency related to employee training. The firm failed to ensure that Quality Control laboratory reviewers were adequately trained and qualified to review laboratory data for drug product release, as evidenced by specific instances involving assay and residual solvents testing.
Open in Dashboard
ID · c7467f98-2056-4d22-a7da-beb60f631ee0